A congressional investigation has revealed that a group of Harvard psychiatrists, instrumental in pushing the diagnosis of bipolar disorder in children and its off-label treatment with antipsychotics, concealed from university officials the millions of dollars they earned in consulting fees for the companies that make those drugs.
Women who suffer from migraines also seem to gain a much lower risk of breast cancer, according to a study released Thursday.
The study is the first of its kind to look at the hormonal relationship between breast cancer and the severe throbbing headaches that can cause vomiting, nausea and sensitivity to light, sound and smells.
Scientists for the first time have decoded the entire genome of a cancer patient, identifying a series of genes never before linked to the type of white blood cell cancer that ultimately killed the woman.
The study, published on Wednesday in the journal Nature, represents a new approach to grasp the genetic underpinning of cancer and pave the way for better treatments
The Supreme Court may rule that pharmaceutical companies cannot be sued for dangerous or even deadly side effects from their drugs if those side effects arise from an FDA-approved use.
Under a legal argument known as "pre-emption," the FDA's approval of a drug absolves companies of any responsibility if that drug later turns out to be dangerous, even if information was concealed from the FDA during the approval process. While courts have rejected this argument for decades, the winds appear to be shifting.
Growing human organs in the laboratory has moved a step closer with the development of a biodegradable material forming a non-living "scaffold" on which beating heart muscle can be grown from stem cells.
The aim is to make three-dimensional organs from scratch, although in the shorter-term scientists will be happy to be able to seed the scaffolding with stem cells in order to mend broken hearts in situ rather than relying on a transplant operation.
Page 191 of 214